Sarepta (SRPT) Skyrockets 35% on Morgan Stanley PT Hike, Stellar Trial Results.
Share this article
Earnings
Score 85
Bullish
Sarepta (SRPT) Skyrockets 35% on Morgan Stanley PT Hike, Stellar Trial Results
Mar 26, 2026 01:09 UTC
SRPT, XLV, IHI
Short term
Related Articles
Score 85
Bearish
BYD Posts Worse-Than-Expected Profit Drop Amid EV Price War
Mar 27, 13:00
Score 85
Bullish
AstraZeneca stock jumps 4% after surprise trial win for lung disease drug where rivals have failed
Mar 27, 12:54
Score 85
Bullish
Novartis Acquires Excellergy for $2 Billion in Latest Biotech M&A Push
Mar 27, 11:43
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.